Laboratorio Reig Jofre S.A (RJF) - Total Liabilities
Based on the latest financial reports, Laboratorio Reig Jofre S.A (RJF) has total liabilities worth €138.18 Million EUR (≈ $161.54 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore how efficiently does Laboratorio Reig Jofre S.A generate cash to assess how effectively this company generates cash.
Laboratorio Reig Jofre S.A - Total Liabilities Trend (2004–2024)
This chart illustrates how Laboratorio Reig Jofre S.A's total liabilities have evolved over time, based on quarterly financial data. Check Laboratorio Reig Jofre S.A liquid asset ratio to evaluate the company's liquid asset resilience ratio.
Laboratorio Reig Jofre S.A Competitors by Total Liabilities
The table below lists competitors of Laboratorio Reig Jofre S.A ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Hexindo Adiperkasa Tbk
JK:HEXA
|
Indonesia | Rp298.70 Million |
|
Perdana Karya Perkasa Tbk
JK:PKPK
|
Indonesia | Rp486.15 Billion |
|
Context Therapeutics Inc
NASDAQ:CNTX
|
USA | $6.06 Million |
|
Bonny Worldwide Ltd
TW:8467
|
Taiwan | NT$1.73 Billion |
|
SmartRent Inc
NYSE:SMRT
|
USA | $101.39 Million |
|
Hanyang Digitech Co. Ltd
KQ:078350
|
Korea | ₩123.53 Billion |
|
Ziprecruiter Inc
NYSE:ZIP
|
USA | $649.70 Million |
Liability Composition Analysis (2004–2024)
This chart breaks down Laboratorio Reig Jofre S.A's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see RJF stock market capitalisation.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.85 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.64 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.39 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Laboratorio Reig Jofre S.A's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Laboratorio Reig Jofre S.A (2004–2024)
The table below shows the annual total liabilities of Laboratorio Reig Jofre S.A from 2004 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | €130.90 Million ≈ $153.04 Million |
+3.65% |
| 2023-12-31 | €126.29 Million ≈ $147.65 Million |
-0.27% |
| 2022-12-31 | €126.64 Million ≈ $148.05 Million |
-7.20% |
| 2021-12-31 | €136.46 Million ≈ $159.54 Million |
+2.86% |
| 2020-12-31 | €132.67 Million ≈ $155.11 Million |
-2.07% |
| 2019-12-31 | €135.48 Million ≈ $158.39 Million |
+93.72% |
| 2018-12-31 | €69.94 Million ≈ $81.76 Million |
+13.20% |
| 2017-12-31 | €61.78 Million ≈ $72.22 Million |
-14.60% |
| 2016-12-31 | €72.34 Million ≈ $84.57 Million |
+18.83% |
| 2015-12-31 | €60.88 Million ≈ $71.17 Million |
-2.71% |
| 2014-12-31 | €62.57 Million ≈ $73.15 Million |
+46.52% |
| 2014-09-30 | €42.70 Million ≈ $49.93 Million |
+424.04% |
| 2013-12-31 | €8.15 Million ≈ $9.53 Million |
-27.92% |
| 2012-12-31 | €11.31 Million ≈ $13.22 Million |
-85.65% |
| 2011-12-31 | €78.79 Million ≈ $92.11 Million |
-28.20% |
| 2010-12-31 | €109.73 Million ≈ $128.29 Million |
+2.95% |
| 2009-12-31 | €106.59 Million ≈ $124.62 Million |
-39.28% |
| 2008-12-31 | €175.55 Million ≈ $205.24 Million |
-0.62% |
| 2007-12-31 | €176.64 Million ≈ $206.51 Million |
+25.06% |
| 2006-12-31 | €141.24 Million ≈ $165.12 Million |
+83.07% |
| 2005-12-31 | €77.15 Million ≈ $90.20 Million |
+397.89% |
| 2004-12-31 | €15.50 Million ≈ $18.12 Million |
-- |
About Laboratorio Reig Jofre S.A
Laboratorio Reig Jofre, S.A., a pharmaceutical company, engages in the research, development, manufacture, and marketing of pharmaceutical products, raw materials, biotechnological products, nutritional supplements, health products, medical devices, cosmetics, parapharmacy, food, and animal food. Its products also include pharmaceutical technologies products, such as antibiotics, and injectables … Read more